Taken together, these results suggest that the PI3K/Akt and MAPK, but not the NF-kappa B, signaling pathways are critical in the upregulation of PD-L1 induced by c-MET amplification in EGFR-TKI resistant NSCLC cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.